Revenue
2018
2019
2020
2021
2022
2023
2024
2025
ABBOTT LABORATORIES (ABT)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B | $34.61B | $31.90B | $30.58B | $27.39B | $20.85B | $20.41B | $20.25B | $19.66B | $19.05B | $21.41B | $35.17B | $30.76B | $29.53B | $25.91B |
| Research & development | $2.94B | $2.84B | $2.74B | $2.89B | $2.74B | $2.42B | $2.44B | $2.30B | $2.26B | $1.45B | $1.41B | $1.34B | $1.37B | $1.46B | $1.51B | $3.72B | $2.74B | $2.69B | $2.51B |
| Operating income | $8.05B | $6.83B | $6.48B | $8.36B | $8.43B | $5.36B | $4.53B | $3.65B | $1.56B | $3.03B | $2.87B | $2.60B | $2.13B | $1.36B | $1.63B | $6.09B | $6.24B | $5.69B | $4.58B |
| EBITDAderived | $11.17B | $10.04B | $9.72B | $11.63B | $11.96B | $8.68B | $7.55B | $6.93B | $4.58B | $4.38B | $4.34B | $4.15B | $3.85B | $4.14B | $4.67B | $8.71B | $8.33B | $7.53B | $6.43B |
| Net income | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B | $4.50B | $3.69B | $2.37B | $477.0M | $1.40B | $4.42B | $2.28B | $2.58B | $5.96B | $4.73B | $4.63B | $5.75B | $4.88B | $3.61B |
| Basic EPSper diluted share | $3.73 | $7.67 | $3.28 | $3.94 | $3.97 | $2.52 | $2.07 | $1.34 | $0.27 | $0.94 | $2.94 | $1.50 | $1.64 | $3.76 | $3.03 | $2.98 | $3.71 | $3.16 | $2.34 |
| Diluted EPSper diluted share | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 | $2.50 | $2.06 | $1.33 | $0.27 | $0.94 | $2.92 | $1.49 | $1.62 | $3.72 | $3.01 | $2.96 | $3.69 | $3.12 | $2.31 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 7, 2026Form 4 | Stratton John GDirector | BuyCommon shares without par value | 2.0K | $86.82 | $173.6K | 23.3K |
| Apr 27, 2026Form 4 | STARKS DANIEL JDirector | BuyCommon shares without par value | 10.0K | $92.65 | $926.5K | 6.75M |
| Apr 23, 2026Form 4 | Boudreau Philip PEVP AND CFO | BuyCommon shares without par value · indirect | 2.2K | $91.50 | $201.3K | 2.2K |
| Mar 2, 2026Form 4 | Cushman Elizabeth C.EVP, GC AND SECRETARY | SellCommon shares without par value | 263 | $115.58 | $30.4K | 38.6K |
| Mar 2, 2026Form 4 | Shroff EricSenior Vice President | SellCommon shares without par value | 709 | $115.58 | $81.9K | 39.2K |